Yitzhak Peterburg (Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA))

Peterburg, Yitzhak (Teva 201702– Interim CEO)

	Organisation	Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)
	Group	Teva (Group)
	Product	pharmaceutical
	Product 2	DRUGS, GENERICS
	Source	Teva Pharmaceutical Industries Ltd.. (2/13/17). "Press Release: Teva Reports Full Year and Fourth Quarter 2016 Financial Results". Jerusalem.

Record changed: 2019-06-09

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Yitzhak Peterburg

[1] Teva Pharmaceutical Industries Ltd.. (8/3/17). "Press Relase: Teva Reports Second Quarter 2017 Financial Results". Jerusalem....
[2] Teva Pharmaceutical Industries Ltd.. (6/6/17). "Press Release: Teva to Present at the Jefferies 2017 Global Healthcare Conference". Jerusalem....
[3] Teva Pharmaceutical Industries Ltd.. (5/11/17). "Press Release: Teva Reports First Quarter 2017 Financial Results". Jerusalem....
[4] Teva Pharmaceutical Industries Ltd.. (2/13/17). "Press Release: Teva Reports Full Year and Fourth Quarter 2016 Financial Results". Jerusalem....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]